TY - JOUR AU - Jiang, J. AU - Zhou, H. AU - Ni, C. AU - Hu, X. AU - Mou, Y. AU - Huang, D. PY - 2019 DA - 2019// TI - Immunotherapy in pancreatic cancer: new hope or mission impossible? JO - Cancer Lett VL - 445 UR - https://doi.org/10.1016/j.canlet.2018.10.045 DO - 10.1016/j.canlet.2018.10.045 ID - Jiang2019 ER - TY - JOUR AU - Wang, X. AU - Lang, M. AU - Zhao, T. AU - Feng, X. AU - Zheng, C. AU - Huang, C. PY - 2017 DA - 2017// TI - Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adeno-carcinoma JO - Oncogene. VL - 36 UR - https://doi.org/10.1038/onc.2016.458 DO - 10.1038/onc.2016.458 ID - Wang2017 ER - TY - STD TI - Wang X, Li X, Wei X, Jiang H, Lan C, Yang S, et.al. PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC. Signal Transduct Target Ther 2020;5:38. ID - ref3 ER - TY - JOUR AU - Huang, C. AU - Li, N. AU - Li, Z. AU - Chang, A. AU - Chen, Y. AU - Zhao, T. PY - 2017 DA - 2017// TI - Tumour-derived interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression JO - Nat Commun VL - 8 UR - https://doi.org/10.1038/ncomms14035 DO - 10.1038/ncomms14035 ID - Huang2017 ER - TY - JOUR AU - Huang, C. AU - Li, Z. AU - Li, N. AU - Li, Y. AU - Chang, A. AU - Zhao, T. PY - 2018 DA - 2018// TI - Interleukin 35 expression correlates with microvessel density in pancreatic ductal adenocarcinoma, recruits monocytes, and promotes growth and angiogenesis of xenograft tumors in mice JO - Gastroenterology. VL - 154 UR - https://doi.org/10.1053/j.gastro.2017.09.039 DO - 10.1053/j.gastro.2017.09.039 ID - Huang2018 ER - TY - JOUR AU - Liu, J. AU - Jiang, W. AU - Zhao, K. AU - Wang, H. AU - Zhou, T. AU - Bai, W. PY - 2019 DA - 2019// TI - Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma JO - J Exp Med VL - 216 UR - https://doi.org/10.1084/jem.20180749 DO - 10.1084/jem.20180749 ID - Liu2019 ER - TY - JOUR AU - Zhao, T. AU - Jiang, W. AU - Wang, X. AU - Wang, H. AU - Zheng, C. AU - Li, Y. PY - 2017 DA - 2017// TI - ESE3 inhibits pancreatic cancer metastasis by upregulating E-Cadherin JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.CAN-16-2170 DO - 10.1158/0008-5472.CAN-16-2170 ID - Zhao2017 ER - TY - JOUR AU - Tang, K. H. AU - Ma, S. AU - Lee, T. K. AU - Chan, Y. P. AU - Kwan, P. S. AU - Tong, C. M. PY - 2012 DA - 2012// TI - CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling JO - Hepatology. VL - 55 UR - https://doi.org/10.1002/hep.24739 DO - 10.1002/hep.24739 ID - Tang2012 ER - TY - JOUR AU - Kindler, H. L. AU - Niedzwiecki, D. AU - Hollis, D. AU - Sutherland, S. AU - Schrag, D. AU - Hurwitz, H. PY - 2010 DA - 2010// TI - Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303) JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2010.28.1386 DO - 10.1200/JCO.2010.28.1386 ID - Kindler2010 ER - TY - JOUR AU - Mahajan, U. M. AU - Langhoff, E. AU - Goni, E. AU - Costello, E. AU - Greenhalf, W. AU - Halloran, C. PY - 2018 DA - 2018// TI - Immune cell and stromal signature associated with progression-free survival of patients with resected pancreatic ductal adenocarcinoma JO - Gastroenterology. VL - 155 UR - https://doi.org/10.1053/j.gastro.2018.08.009 DO - 10.1053/j.gastro.2018.08.009 ID - Mahajan2018 ER -